Simon Francis Thomsen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria (NCT05916937) | Simon Francis Thomsen | 2024-01-12 |
Track Simon Francis Thomsen automatically
Every clearance here is in the API, with alerts when new ones post.